Best Pet Insurance for Basenjis

Fanconi Syndrome is the defining health condition of the Basenji breed. It is a kidney tubule disorder that causes the kidneys to fail to properly reabsorb electrolytes and other nutrients, leading to their loss in urine. Without treatment, it is fatal. A DNA test is available (Fanconi DNA Test); the condition was documented to affect approximately 10% of Basenjis in earlier studies. Urinary strip testing starting at age 3 can detect the condition early. Treatment involves oral supplementation of lost electrolytes and bicarbonate ($50–$200/month). Well-managed Basenjis can live normal lifespans.

PRA is documented in Basenjis, causing progressive degeneration of the retina and eventual blindness. A DNA test is available for the breed-specific form. Night blindness is the earliest sign, progressing to total vision loss. There is no curative treatment; dogs adapt well to vision loss in stable environments. Annual CAER ophthalmology exams ($150–$300) monitor progression. All Basenjis used for breeding should be DNA-tested and ophthalmology-certified to reduce PRA prevalence.

Hypothyroidism occurs at moderate rates in Basenjis. The breed's lean, athletic physique means weight gain — a primary sign of hypothyroidism — is more readily noticed than in heavier breeds. Other signs include lethargy, skin changes, and behavioral changes. Diagnosis via thyroid panel bloodwork ($100–$250). Daily levothyroxine ($20–$40/month for this small breed) is inexpensive and highly effective. Semi-annual monitoring bloodwork maintains optimal hormone levels.

Immunoproliferative Enteropathy (Basenji enteropathy) is a breed-specific inflammatory bowel disease resembling human tropical sprue. It causes protein-losing enteropathy, chronic diarrhea, weight loss, and malabsorption. Diagnosis involves endoscopy and intestinal biopsy ($800–$1,500). Treatment includes immunosuppressive therapy (prednisolone, metronidazole) and specialized diet ($200–$500/month). The condition can be managed but not cured; some dogs achieve long remissions while others have recurrent flares. Progressive cases carry a guarded prognosis.

Hip dysplasia occurs at low but notable rates in Basenjis. Despite the breed's small size and lean, athletic build, the condition can still cause arthritis and mobility issues. OFA health testing is recommended for breeding stock. Medical management costs $300–$1,000/year for mild cases. FHO surgery ($1,500–$3,000) or total hip replacement ($4,500–$6,000) may be needed for severe disease. Maintaining a lean, muscular body condition throughout life reduces disease progression.